Friday, May 24, 2019 9:54:21 AM
Given this, common sense tells me that they would NOT co-construct and enter into an agreement that was unrealistic to achieve...
..they know all bets are off on their pricing deal if they don't hit these targets...they could have easily negotiated a slightly worse pricing deal with lower targets...so why didn't they?? I'll tell you why, because Cramer is very confident they can hit these targets!
Companies as savvy as Cramer don't just guess at stuff like this! I guarantee you they already have customers chomping at the bit for PatScan VRS (as the press release indicates)...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM